Corporate calendar for Arvinas, Inc. (ARVN): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate disease-causing proteins. The company's pipeline features several promising candidates.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | ||
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 |
Price
| Price | $8.16 |
| Market Cap | $526M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 19 |
| Hold | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 26 |
| Avg rating (1-5) | 0.69 |
Related companies: ATXS · AVBP · DAWN · DNA · ERAS · GERN · IOVA
Explore sector: Healthcare · Biotechnology
More sections of ARVN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks